Pitch Showcase: SereNeuro Therapeutics

SPEAKER:

Daniel Saragnese
Co-Founder, SereNeuro Therapeutics
Dan Saragnese brings extensive experience in biotechnology drug development and manufacturing operations, having successfully advanced multiple therapeutic candidates from preclinical stages through clinical development at venture-backed spin-outs from Stanford and Johns Hopkins University. Dan’s career includes leadership roles at Earli, Inc. ($40M Series A), Ashvattha Therapeutics ($69M Series B), Graybug Vision (NASDAQ: GRAY), and Blackstone PortCo Catalent, Inc. (NYSE:CTLT). Read full profile…